GK interview with Ross Greenwood, page-4

The long-running investigation has taken its toll, however, and Dr Kelly, who specialised in anti-cancer drugs, has retired to a farm, battling the prostate cancer he was diagnosed with last year.
"How has (the Wickenby investigation) affected me? I have terminal cancer, the effect of this whole thing has been a contributor to that," he said. (July 2009)

To sell the drugs developed by  Triaxial
"But he said that he had beaten the cancer.
"I'm fine," he said yesterday.
"I had radiology and chemotherapy and then I took it upon myself to treat myself with some of my own drugs. I'm in remission."  (Dec 2012).

To sell  CS6  
"Certainly you can't accuse Dr Kelly of not believing in the product - he used a couple of earlier, less-powerful versions of the drug on himself when suffering advanced and aggressive prostate cancer and is now in remission and feeling great".  (Aug 2013)

To sell  the compound TR100
"Big pharmaceutical companies claim you can’t develop a breakthrough cancer treatment for less than $1.5 billion but Novogen chief Graham Kelly, who is using his own experimental cancer medicine on himself to beat his aggressive prostate cancer, accuses them of “obscene” price gouging. (May 2014)

To sell NOX66
"Ahead of listing his latest cancer drug play, biotech entrepreneur and cancer survivor Graham Kelly has took the time-honoured, albeit controversial, route of medical development: self-experimentation.  (Aug 2016).

Makeup up your minds.  But you are dealing with a salesman who has used  his recovery from cancer to push four different drug compounds to rise money from brian to ovianary cancer.